Dobutamine — Discount Pricing

Other medications in Heart & Cardiovascular

• Dronedarone
• Empagliflozin (HF)
• Enalapril
• Eplerenone
• Epoprostenol
• Eprosartan
• Evolocumab
• Ezetimibe

About Dobutamine

Dobutamine is a powerful medication often used in critical care to help a struggling heart pump more effectively, typically for conditions like heart failure. While often administered in a hospital setting, understanding its role and potential costs is important. TheDrugClub is dedicated to helping members find significant savings on a wide range of prescriptions, ensuring vital medications are more accessible.

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Dobutamine is approved for (FDA label)

Dobutamine Injection, USP is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of adults with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures. In patients who have atrial fibrillation with rapid ventricular response, a digitalis preparation should be used prior to institution of therapy with dobutamine hydrochloride.

Source: Read the full FDA label on DailyMed. Label effective date: May 27, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Dobutamine (FDA label)

Increased Heart Rate, Blood Pressure, and Ventricular Ectopic Activity − A 10 to 20 mm increase in systolic blood pressure and an increase in heart rate of 5 to 15 beats/minute have been noted in most patients (see WARNINGS regarding exaggerated chronotropic and pressor effects). Approximately 5% of patients have had increased premature ventricular beats during infusions. These effects are dose related. Hypotension − Precipitous decreases in blood pressure have occasionally been described in association with dobutamine therapy. Decreasing the dose or discontinuing the infusion typically results in rapid return of blood pressure to baseline values. In rare cases, however, intervention may be required and reversibility may not be immediate.

Source: FDA prescribing information (DailyMed). Set ID: 89becb0c-da60-4f43-0a98-29ff7a9eca58. SPL document ID: f6a67673-07a7-44e4-b05c-1f7e63326f79. Label effective date: May 27, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Dobutamine (FDA label)

Dobutamine hydrochloride is contraindicated in patients with idiopathic hypertrophic subaortic stenosis and in patients who have shown previous manifestations of hypersensitivity to Dobutamine Injection, USP solution.

Source: FDA prescribing information (DailyMed). Set ID: 89becb0c-da60-4f43-0a98-29ff7a9eca58. SPL document ID: f6a67673-07a7-44e4-b05c-1f7e63326f79. Label effective date: May 27, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Dobutamine (FDA label)

Drug Interactions – Animal studies indicate that dobutamine may be ineffective if the patient has recently received a β-blocking drug. In such a case, the peripheral vascular resistance may increase. Preliminary studies indicate that the concomitant use of dobutamine and nitroprusside results in a higher cardiac output and, usually, a lower pulmonary wedge pressure than when either drug is used alone. There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, nitroglycerin, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.

Source: FDA prescribing information (DailyMed). Set ID: 89becb0c-da60-4f43-0a98-29ff7a9eca58. SPL document ID: f6a67673-07a7-44e4-b05c-1f7e63326f79. Label effective date: May 27, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.